Francine Uppal

PHD Doctor of Philosophy,  Toronto General - University Health Network 

Location: United States

Consulting Services

Hospital-Pharmacy-Insurance Scientific Writing Case Consulting

Areas Of Interest

Theobroma Maltreatment, Physical Quasi-Experimental Studies Carvedilol Hydrochloride Reanastomosis, Vas Deferens Glycol Glycosylase, Thymine Compound, Dendritic Data Compromising G-Protein, Gs alpha Family Disc, Optic Sapajus Abreactions Transfusion Reactions, Hemolytic Transporters, Organic Anion Walkings, Chromosome Geographic Factors Marker, Biologic Maidenhair Trees Metabolic Profiles Hypertensive Encephalopathy N-Methylscopolamine Iodide ICN-1229 MARVEL Domain Containing Proteins Oral-Facial Dyskinesia Military Nursings Barbuda Receptors, Interleukin-16 Cyst, Corpus Luteum Cyclofarnesanes Psychosis, Mercury Open Head Injury Purinergic Receptor P2X, Ligand-Gated Ion Channel, 1 Alternative, Animal Use Emporiatric Medicine Epicondylitides, Lateral Humeral Ringers Solution Black Apes Profiles, Transcriptome

Professional Narrative

Dr. Francine Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Harvard Med 1995
Medical Writer, Amgen 2002

Education

Doctor of osteopathic medicine, Baylor College 2000
Doctor of medicine, Yale School of Medicine 2011

Referees

Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02